Poseida Therapeutics, Inc.
Clinical trials sponsored by Poseida Therapeutics, Inc., explained in plain language.
-
15-Year watch: tracking patients after experimental cell therapy for blood cancer
Disease control OngoingThis study is tracking patients for 15 years after they received an experimental cell therapy called P-BCMA-101 for multiple myeloma, a type of blood cancer. The goal is to monitor for any long-term side effects and see how well the treatment continues to work over time. It is fo…
Phase: PHASE1 • Sponsor: Poseida Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New 'Universal' cancer therapy enters human testing
Disease control OngoingThis is a first-in-human study testing a new type of cancer treatment called P-MUC1C-ALLO1 in adults with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose and see how well the body tolerates this 'off-the-shelf' CAR-T …
Phase: PHASE1 • Sponsor: Poseida Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC